These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9305413)

  • 21. Seizure vulnerability and anxiety responses following chronic co-administration and acute withdrawal of caffeine and ethanol in a rat model.
    Matovu D; Alele PE
    J Basic Clin Physiol Pharmacol; 2018 Jan; 29(1):1-10. PubMed ID: 29127761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Peripheral κ-Opioid Receptors Normalizes Caffeine Effects Modified in Nicotine-Dependent Rats during Nicotine Withdrawal.
    Sudakov SK; Bogdanova NG
    Bull Exp Biol Med; 2016 Oct; 161(6):743-745. PubMed ID: 27785643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (-)-Epigallocatechin-3-O-gallate (EGCG) reverses caffeine-induced anxiogenic-like effects.
    Park KS; Oh JH; Yoo HS; Lee YM; Lee MK; Hong JT; Oh KW
    Neurosci Lett; 2010 Sep; 481(2):131-4. PubMed ID: 20599478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze.
    Navarro JF; Maldonado E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1151-4. PubMed ID: 12452538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal.
    File SE; Andrews N
    Psychopharmacology (Berl); 1991; 105(4):578-82. PubMed ID: 1771225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Pachuta A; Bochenski M; Silberring J
    Peptides; 2009 Jun; 30(6):1165-72. PubMed ID: 19463751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for anxiolytic effects of acute caffeine on anxiety-related behavior in male and female rats tested with and without bright light.
    Hughes RN; Hancock NJ; Henwood GA; Rapley SA
    Behav Brain Res; 2014 Sep; 271():7-15. PubMed ID: 24875772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Social separation and diazepam withdrawal increase anxiety in the elevated plus-maze and serotonin turnover in the median raphe and hippocampus.
    dos Santos L; de Andrade TG; Graeff FG
    J Psychopharmacol; 2010 May; 24(5):725-31. PubMed ID: 19939879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FG7142, yohimbine, and βCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta.
    Yeung M; Lu L; Hughes AM; Treit D; Dickson CT
    Neuropharmacology; 2013 Dec; 75():47-52. PubMed ID: 23851259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.
    Pellow S; Chopin P; File SE; Briley M
    J Neurosci Methods; 1985 Aug; 14(3):149-67. PubMed ID: 2864480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.
    Abrams JK; Johnson PL; Hay-Schmidt A; Mikkelsen JD; Shekhar A; Lowry CA
    Neuroscience; 2005; 133(4):983-97. PubMed ID: 15916857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal.
    Irvine EE; Cheeta S; File SE
    Pharmacol Biochem Behav; 2001 Feb; 68(2):319-25. PubMed ID: 11267637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiogenic activity of isatin, a putative biological factor, in rodents.
    Bhattacharya SK; Mitra SK; Acharya SB
    J Psychopharmacol; 1991 Jan; 5(3):202-6. PubMed ID: 22282556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic exposure to noise modifies the anxiogenic response, but not the hypoactivity, detected on withdrawal from chronic ethanol treatment.
    File SE
    Psychopharmacology (Berl); 1994 Nov; 116(3):369-72. PubMed ID: 7892429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls.
    Anseloni VZ; Motta V; Lima G; Brandão ML
    Braz J Med Biol Res; 1995 May; 28(5):597-601. PubMed ID: 8555981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of anxiogenic drugs on the emission of 22- and 50-kHz ultrasonic vocalizations in adult rats.
    Willadsen M; Best LM; Wöhr M; Clarke PBS
    Psychopharmacology (Berl); 2018 Aug; 235(8):2435-2445. PubMed ID: 29909426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism of kynurenic acid to anxiogens in mice.
    Lapin IP
    Life Sci; 1998; 63(15):PL231-6. PubMed ID: 9768878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiogenic effects of the intraamygdala injection of flumazenil, a benzodiazepine receptor antagonist.
    Da Cunha C; Wolfman C; Levi de Stein M; Ruschel AC; Izquierdo I; Medina JH
    Funct Neurol; 1992; 7(5):401-5. PubMed ID: 1338052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat.
    File SE; Johnston AL
    Neuropsychobiology; 1987; 17(4):187-92. PubMed ID: 2894617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiogenesis in adult rats treated chronically with cocaine during adolescence: effects of extended abstinence and 8-OH-DPAT treatment.
    Santucci AC; Madeira E
    Brain Res Bull; 2008 Jul; 76(4):402-11. PubMed ID: 18502317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.